Prakash Nagarkatti
Prakash Nagarkatti
Vice President for Research, University of South Carolina
Verified email at - Homepage
Cited by
Cited by
Cannabinoids as novel anti-inflammatory drugs
P Nagarkatti, R Pandey, SA Rieder, VL Hegde, M Nagarkatti
Future medicinal chemistry 1 (7), 1333-1349, 2009
Role of cytokines as a double-edged sword in sepsis
H Chaudhry, J Zhou, YIN Zhong, MM Ali, F McGuire, PS Nagarkatti, ...
In vivo 27 (6), 669-684, 2013
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease
RJ McKallip, C Lombard, M Fisher, BR Martin, S Ryu, S Grant, ...
Blood, The Journal of the American Society of Hematology 100 (2), 627-634, 2002
Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen …
L Qiao, E Studer, K Leach, R McKinstry, S Gupta, R Decker, R Kukreja, ...
Molecular biology of the cell 12 (9), 2629-2645, 2001
Δ-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response
RJ McKallip, M Nagarkatti, PS Nagarkatti
The Journal of Immunology 174 (6), 3281-3289, 2005
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
SA Rieder, A Chauhan, U Singh, M Nagarkatti, P Nagarkatti
Immunobiology 215 (8), 598-605, 2010
Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis
NP Singh, UP Singh, B Singh, RL Price, M Nagarkatti, PS Nagarkatti
PloS one 6 (8), e23522, 2011
Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner
R Mehla, S Bivalkar-Mehla, R Zhang, I Handy, H Albrecht, S Giri, ...
PloS one 5 (6), e11160, 2010
Resveratrol suppresses colitis and colon cancer associated with colitis
X Cui, Y Jin, AB Hofseth, E Pena, J Habiger, A Chumanevich, D Poudyal, ...
Cancer prevention research 3 (4), 549-559, 2010
Endocannabinoids and immune regulation
R Pandey, K Mousawy, M Nagarkatti, P Nagarkatti
Pharmacological research 60 (2), 85-92, 2009
Cannabidiol-induced apoptosis in human leukemia cells: a novel role of cannabidiol in the regulation of p22phox and Nox4 expression
RJ McKallip, W Jia, J Schlomer, JW Warren, PS Nagarkatti, M Nagarkatti
Molecular Pharmacology 70 (3), 897-908, 2006
Resveratrol (trans-3, 5, 4′-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-κB activation to abrogate …
UP Singh, NP Singh, B Singh, LJ Hofseth, RL Price, M Nagarkatti, ...
Journal of Pharmacology and Experimental Therapeutics 332 (3), 829-839, 2010
Chemokine and cytokine levels in inflammatory bowel disease patients
UP Singh, NP Singh, EA Murphy, RL Price, R Fayad, M Nagarkatti, ...
Cytokine 77, 44-49, 2016
Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-κB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation
Y Do, RJ McKallip, M Nagarkatti, PS Nagarkatti
The Journal of Immunology 173 (4), 2373-2382, 2004
Resveratrol (trans-3, 5, 4′-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of …
NP Singh, VL Hegde, LJ Hofseth, M Nagarkatti, P Nagarkatti
Molecular pharmacology 72 (6), 1508-1521, 2007
Δ9-Tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo
RJ McKallip, C Lombard, BR Martin, M Nagarkatti, PS Nagarkatti
Journal of Pharmacology and Experimental Therapeutics 302 (2), 451-465, 2002
Antimicrobial metallopolymers and their bioconjugates with conventional antibiotics against multidrug-resistant bacteria
J Zhang, YP Chen, KP Miller, MS Ganewatta, M Bam, Y Yan, M Nagarkatti
Journal of the American Chemical Society, 2014
Evidence for the induction of apoptosis in thymocytes by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxinin vivo
AB Kamath, H Xu, PS Nagarkatti, M Nagarkatti
Toxicology and applied pharmacology 142 (2), 367-377, 1997
Expression, regulation and function of microRNAs in multiple sclerosis
X Ma, J Zhou, Y Zhong, L Jiang, P Mu, Y Li, N Singh, M Nagarkatti, ...
International journal of medical sciences 11 (8), 810, 2014
Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells
VL Hegde, S Hegde, BF Cravatt, LJ Hofseth, M Nagarkatti, PS Nagarkatti
Molecular pharmacology 74 (1), 20-33, 2008
The system can't perform the operation now. Try again later.
Articles 1–20